FR2407930A1 - Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparation - Google Patents
Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparationInfo
- Publication number
- FR2407930A1 FR2407930A1 FR7831339A FR7831339A FR2407930A1 FR 2407930 A1 FR2407930 A1 FR 2407930A1 FR 7831339 A FR7831339 A FR 7831339A FR 7831339 A FR7831339 A FR 7831339A FR 2407930 A1 FR2407930 A1 FR 2407930A1
- Authority
- FR
- France
- Prior art keywords
- methylcyten
- unctyl
- trifluoromethyl
- methylcyl
- alcoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- -1 HYDROXY TRIFLUOROMETHYL Chemical class 0.000 abstract 11
- 150000002367 halogens Chemical group 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- ZYVYEJXMYBUCMN-UHFFFAOYSA-N 1-methoxy-2-methylpropane Chemical class COCC(C)C ZYVYEJXMYBUCMN-UHFFFAOYSA-N 0.000 abstract 1
- KCUQVAUQRGDGKP-UHFFFAOYSA-N 5,11,17,23-tetrakis(1,1,3,3-tetramethylbutyl)calix[4]arene-25,26,27,28-tetrol Chemical compound C1C(C=2O)=CC(C(C)(C)CC(C)(C)C)=CC=2CC(C=2O)=CC(C(C)(C)CC(C)(C)C)=CC=2CC(C=2O)=CC(C(C)(C)CC(C)(C)C)=CC=2CC2=CC(C(C)(C)CC(C)(C)C)=CC1=C2O KCUQVAUQRGDGKP-UHFFFAOYSA-N 0.000 abstract 1
- 241000422193 Ormyrus Species 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical class [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 abstract 1
- XIPUIGPNIDKXJU-UHFFFAOYSA-N [CH]1CC1 Chemical class [CH]1CC1 XIPUIGPNIDKXJU-UHFFFAOYSA-N 0.000 abstract 1
- BQOWUDKEXDCGQS-UHFFFAOYSA-N [CH]1CCCC1 Chemical class [CH]1CCCC1 BQOWUDKEXDCGQS-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229940125716 antipyretic agent Drugs 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003178 carboxy group Chemical class [H]OC(*)=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- CBCIHIVRDWLAME-UHFFFAOYSA-N hexanitrodiphenylamine Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O CBCIHIVRDWLAME-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 125000000956 methoxy group Chemical class [H]C([H])([H])O* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4616677 | 1977-11-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2407930A1 true FR2407930A1 (fr) | 1979-06-01 |
| FR2407930B1 FR2407930B1 (enExample) | 1983-03-18 |
Family
ID=10440127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7831339A Granted FR2407930A1 (fr) | 1977-11-07 | 1978-11-06 | Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparation |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4293549A (enExample) |
| JP (1) | JPS5473784A (enExample) |
| AT (1) | AT366368B (enExample) |
| AU (1) | AU517670B2 (enExample) |
| BE (1) | BE871807A (enExample) |
| CA (1) | CA1120929A (enExample) |
| CH (1) | CH645354A5 (enExample) |
| DE (1) | DE2847792A1 (enExample) |
| DK (1) | DK153950C (enExample) |
| ES (1) | ES474900A1 (enExample) |
| FI (1) | FI69463C (enExample) |
| FR (1) | FR2407930A1 (enExample) |
| GR (1) | GR65010B (enExample) |
| IE (1) | IE47458B1 (enExample) |
| IT (1) | IT1100075B (enExample) |
| LU (1) | LU80476A1 (enExample) |
| NL (1) | NL7811035A (enExample) |
| NZ (1) | NZ188770A (enExample) |
| PH (1) | PH16296A (enExample) |
| PT (1) | PT68750A (enExample) |
| SE (1) | SE446267B (enExample) |
| SU (1) | SU828967A3 (enExample) |
| YU (1) | YU41129B (enExample) |
| ZA (1) | ZA786175B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306846B1 (en) * | 1972-05-31 | 2001-10-23 | John R. J. Sorenson | Anti-inflammatory and anti-ulcer compounds and process |
| IT1205640B (it) * | 1983-04-06 | 1989-03-23 | Yason Srl | Nuovi composti ad attivita' antiinfiammatoria,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
| US4563460A (en) * | 1984-01-13 | 1986-01-07 | William H. Rorer, Inc. | Quinoline and quinazoline derivatives for treating gastrointestinal motility dysfunctions |
| HU195487B (en) * | 1985-06-04 | 1988-05-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing quinoline derivatives |
| ATE66477T1 (de) * | 1986-08-29 | 1991-09-15 | Pfizer | 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren. |
| US6100260A (en) * | 1997-04-21 | 2000-08-08 | Sumitomo Pharmaceutical Company, Limited | Isoxazole derivatives |
| EP0928793B1 (en) * | 1998-01-02 | 2002-05-15 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
| HUP0101275A3 (en) * | 1998-03-26 | 2002-12-28 | Japan Tobacco Inc | Amide derivatives and pharmaceutical compositions containing them as nociceptin antagonists |
| WO2001032604A1 (en) * | 1999-11-05 | 2001-05-10 | University College London | Activators of soluble guanylate cyclase |
| US7186725B2 (en) * | 2003-01-03 | 2007-03-06 | Genzyme Corporation | Anti-inflammatory compositions and methods |
| CA2511970C (en) * | 2003-01-14 | 2012-06-26 | Cytokinetics, Inc. | Urea derivatives useful in the treatment of heart failure |
| GB0404434D0 (en) * | 2004-02-27 | 2004-03-31 | Novartis Ag | Organic compounds |
| WO2007022964A2 (de) * | 2005-08-24 | 2007-03-01 | Abbott Gmbh & Co. Kg | Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
| CN117677386A (zh) * | 2021-07-23 | 2024-03-08 | 瓦伦塔有限责任公司 | 具有亲溶酶体和抗病毒活性的化合物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB889262A (en) * | 1959-07-03 | 1962-02-14 | Ciba Ltd | Quinoline compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB889282A (en) * | 1957-05-07 | 1962-02-14 | Air Reduction | Preparation of hexafluorodiethyl ether and medicinal compositions containing it |
| US3159676A (en) * | 1962-02-07 | 1964-12-01 | Smith Kline French Lab | Naphthyl containing guanidines |
| US3852293A (en) | 1972-06-21 | 1974-12-03 | Uniroyal Inc | 4-phenyl-2-(3-pyridyl)-thiazole carboxamides |
| US4000279A (en) * | 1974-10-29 | 1976-12-28 | Armour Pharmaceutical Company | Pharmaceutical preparations containing 5'-(8'-hydroxyquinolyl)guanidine compounds and methods of using same |
-
1978
- 1978-10-20 IE IE2084/78A patent/IE47458B1/en not_active IP Right Cessation
- 1978-10-26 GR GR57518A patent/GR65010B/el unknown
- 1978-10-27 US US05/955,228 patent/US4293549A/en not_active Expired - Lifetime
- 1978-10-30 AT AT0773278A patent/AT366368B/de not_active IP Right Cessation
- 1978-10-30 NZ NZ188770A patent/NZ188770A/en unknown
- 1978-10-31 CA CA000315384A patent/CA1120929A/en not_active Expired
- 1978-11-01 FI FI783327A patent/FI69463C/fi not_active IP Right Cessation
- 1978-11-02 ZA ZA00786175A patent/ZA786175B/xx unknown
- 1978-11-02 PH PH21790A patent/PH16296A/en unknown
- 1978-11-03 DE DE19782847792 patent/DE2847792A1/de active Granted
- 1978-11-03 CH CH1136378A patent/CH645354A5/de not_active IP Right Cessation
- 1978-11-04 SU SU782685598A patent/SU828967A3/ru active
- 1978-11-06 YU YU2575/78A patent/YU41129B/xx unknown
- 1978-11-06 FR FR7831339A patent/FR2407930A1/fr active Granted
- 1978-11-06 JP JP13723578A patent/JPS5473784A/ja active Granted
- 1978-11-06 LU LU80476A patent/LU80476A1/xx unknown
- 1978-11-06 AU AU41376/78A patent/AU517670B2/en not_active Expired
- 1978-11-06 DK DK493378A patent/DK153950C/da not_active IP Right Cessation
- 1978-11-06 SE SE7811457A patent/SE446267B/sv not_active IP Right Cessation
- 1978-11-06 BE BE191566A patent/BE871807A/xx not_active IP Right Cessation
- 1978-11-06 NL NL7811035A patent/NL7811035A/xx not_active Application Discontinuation
- 1978-11-06 PT PT68750A patent/PT68750A/pt unknown
- 1978-11-07 IT IT29514/78A patent/IT1100075B/it active
- 1978-11-07 ES ES474900A patent/ES474900A1/es not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB889262A (en) * | 1959-07-03 | 1962-02-14 | Ciba Ltd | Quinoline compounds |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1314184B1 (it) | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo | |
| FR2453853A1 (fr) | Nouveaux derives d'o-(4-diphenylmethylpiperidino)-alcanophenones utiles notamment comme antihistaminiques, et leur procede de preparation | |
| TNSN97127A1 (fr) | Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant | |
| TNSN86111A1 (fr) | Procede de preparation d'hydroxyalkylxanthines tertiaires | |
| CZ15795A3 (en) | Derivatives of hydroxamic acid, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof | |
| NZ219104A (en) | Phenol derivatives as pharmaceuticals | |
| FR2452485A1 (fr) | Nouveaux acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere | |
| DK0583421T3 (da) | Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse | |
| KR890005031A (ko) | L-도파유도체 또는 그의 산부가염, 그의 제조방법 및 그의 용도 | |
| CA2412932A1 (en) | Pleuromutilin derivatives having antibacterial activity | |
| CO4700291A1 (es) | Compuestos quimicos | |
| DE3676179D1 (de) | N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
| RU94039539A (ru) | N,n'-замещенные имидокарбонимидные диамиды, получаемые из гидроксиламинов, имеющие антимикробную и антипаразитическую активность, профилактическая композиция, композиция для снижения уровня инфекций | |
| TW200505438A (en) | Method of treating cancer with azaspirane compositions | |
| FR2366285A1 (fr) | (3-amino-5-substitue-6-fluoropyrazinoyl ou pyrazamido) guanidines et leurs derives portant des substituants sur les atomes d'azote du noyau de guanidine, utiles comme medicaments | |
| GB1113391A (en) | Biologically active dithiosemicarbazones | |
| TNSN93107A1 (fr) | Derives de piperidine, leur preparation et leur application en therapeutique | |
| KR880009003A (ko) | 5-(3-알킬-5-3급 부틸-4-히드록시페닐)-2-아미노-6h-1,3,4-티아디아진, 이의 제조방법, 이를 포함하는 약제 및 이의 용도 | |
| EA200000389A3 (ru) | Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции | |
| FR2439774A1 (fr) | Nouveaux derives de crysteine utiles notamment comme medicaments pour la suppression des troubles hepatiques et procedes pour leur preparation | |
| GB1031425A (en) | New aralkylamines and their preparation | |
| ES2059348T3 (es) | Composicion farmaceutica para el tratamiento de cataratas. | |
| IT1213301B (it) | Composizioni per il trattamento del le sindromi da ischemia e riperfusione | |
| KR890003692A (ko) | 1.2.5.6- 테트라히드로피리딘-3-카르복스알데히드의 옥심유도체, 이들의 제조방법, 약제로서의 이들의 용도 및 이들을 함유하는 조성물 | |
| FR2444673A1 (fr) | Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| ST | Notification of lapse |